These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 10804020)

  • 21. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
    Uchiyama S; Yamaguchi M
    Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts.
    Ortiz CO; Chen BK; Bale LK; Overgaard MT; Oxvig C; Conover CA
    J Bone Miner Res; 2003 Jun; 18(6):1066-72. PubMed ID: 12817760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regucalcin stimulates osteoclast-like cell formation in mouse marrow cultures.
    Yamaguchi M; Uchiyama S
    J Cell Biochem; 2005 Mar; 94(4):794-803. PubMed ID: 15578574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors.
    Chikazu D; Shindo M; Iwasaka T; Katagiri M; Manabe N; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2000 Apr; 15(4):674-82. PubMed ID: 10780859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.
    Jimi E; Nakamura I; Duong LT; Ikebe T; Takahashi N; Rodan GA; Suda T
    Exp Cell Res; 1999 Feb; 247(1):84-93. PubMed ID: 10047450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor binding protein (IGFBP)-mediated hair cell survival on the mouse utricle exposed to neomycin: the roles of IGFBP-4 and IGFBP-5.
    Park JY; Park YH; Shin DH; Oh SH
    Acta Otolaryngol Suppl; 2007 Oct; (558):22-9. PubMed ID: 17882566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
    McCarthy TL; Casinghino S; Centrella M; Canalis E
    J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts.
    Yates AJ; Oreffo RO; Mayor K; Mundy GR
    J Bone Miner Res; 1991 May; 6(5):473-8. PubMed ID: 2068953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carboxyl-terminal peptides from parathyroid hormone-related protein stimulate osteoclast-like cell formation.
    Kaji H; Sugimoto T; Kanatani M; Fukase M; Chihara K
    Endocrinology; 1995 Mar; 136(3):842-8. PubMed ID: 7867592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5.
    Rutter MM; Markoff E; Clayton L; Akeno N; Zhao G; Clemens TL; Chernausek SD
    Bone; 2005 Feb; 36(2):224-31. PubMed ID: 15780948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone receptor activity is stimulated by insulin-like growth factor binding protein 5 in rat osteosarcoma cells.
    Slootweg MC; Ohlsson C; van Elk EJ; Netelenbos JC; Andress DL
    Growth Regul; 1996 Dec; 6(4):238-46. PubMed ID: 8971553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage colony stimulating factor increases bone resorption in dispersed osteoclast cultures by increasing osteoclast size.
    Lees RL; Heersche JN
    J Bone Miner Res; 1999 Jun; 14(6):937-45. PubMed ID: 10352102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An assay system utilizing devitalized bone for assessment of differentiation of osteoclast progenitors.
    Amano S; Hanazawa S; Kawata Y; Ohta K; Kitami H; Kitano S
    J Bone Miner Res; 1992 Mar; 7(3):321-8. PubMed ID: 1585834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
    Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K
    J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoclast formation in bone marrow cultures from two inbred strains of mice with different bone densities.
    Linkhart TA; Linkhart SG; Kodama Y; Farley JR; Dimai HP; Wright KR; Wergedal JE; Sheng M; Beamer WG; Donahue LR; Rosen CJ; Baylink DJ
    J Bone Miner Res; 1999 Jan; 14(1):39-46. PubMed ID: 9893064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoic acid induces osteoclast-like cell formation by directly acting on hemopoietic blast cells and stimulates osteopontin mRNA expression in isolated osteoclasts.
    Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
    Life Sci; 1995; 56(22):1903-13. PubMed ID: 7746099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of the insulin-like growth factor I receptor in mature rabbit osteoclasts.
    Hou P; Sato T; Hofstetter W; Foged NT
    J Bone Miner Res; 1997 Apr; 12(4):534-40. PubMed ID: 9101364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts.
    de Vries TJ; Mullender MG; van Duin MA; Semeins CM; James N; Green TP; Everts V; Klein-Nulend J
    Mol Cancer Res; 2009 Apr; 7(4):476-88. PubMed ID: 19372577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.